KTTA: Pasithea Therapeutics Corp. Stock

by  •  • Comments Off on KTTA: Pasithea Therapeutics Corp. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.10
Enterprise Value ($M) -3.86
Book Value ($M) 16.18
Book Value / Share 15.49
Price / Book 0.25
NCAV ($M) 7.15
NCAV / Share 6.85
Price / NCAV 0.57

Profitability (mra)
Return on Invested Capital (ROIC) -1.01
Return on Assets (ROA) -0.43
Return on Equity (ROE) -0.46

Liquidity (mrq)
Quick Ratio 6.20
Current Ratio 6.20

Balance Sheet (mrq) ($M)
Current Assets 8.64
Assets 17.66
Liabilities 1.49
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -15.98
Net Income -15.96

Cash Flow Statement (mra) ($M)
Cash From Operations -13.43
Cash from Investing 0.40
Cash from Financing -3.73

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-09-13 270 3,340 8.08
2024-09-12 3,190 11,040 28.89
2024-09-11 1 1,892 0.05
2024-09-10 2,002 17,874 11.20

(click for more detail)

Similar Companies
KPRX – Kiora Pharmaceuticals, Inc. KRRO – Korro Bio, Inc.
KTRA – Kintara Therapeutics, Inc. KZR – Kezar Life Sciences, Inc.
LEXX – Lexaria Bioscience Corp.


Financial data and stock pages provided by
Fintel.io